MADISON, N.J., June 22, 2011 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced a new version of Gazelle, the company's mobile health platform, which now features compatibility with the fast-growing Google Android® smartphone operating system.
Gazelle for Android is now available for download free of charge at Gazelleapp.com and in the Android Market at market.android.com. Gazelle was originally introduced in October of last year for the Apple iPhone® and BlackBerry® platforms.
With Gazelle, patients in 33 states and the District of Columbia can receive their Quest Diagnostics laboratory test results directly on their smartphone. In addition, users can see, store and share their vital health information with ease and security while on the go.
"Quest Diagnostics is committed to empowering patients to take charge of their health," said Neil Desai, General Manager, Mobile Health, Quest Diagnostics. "With the availability of Gazelle for Android, we have expanded the reach and capabilities of our revolutionary health management platform."
Among the new features in the latest release of Gazelle:
- Improved information sharing capabilities for email and fax;
- And, based on user suggestions, the ability to add contact information for multiple pharmacies and insurance companies in a single account.
Gazelle also features a mobile appointment scheduling application that allows patients to either enter their zip code to find a local Quest Diagnostics location, or to use the smartphone's GPS capability, which automatically identifies the patient's current location and displays the next available appointment times at the closest Quest Diagnostics locations.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at www.QuestDiagnostics.com or follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.
Glen Brandow (Media): 973-520-2800 or [email protected]
Kathleen Valentine (Investors): 973-520-2900
SOURCE Quest Diagnostics